Surmodics Revenue and Competitors

Location

N/A

Total Funding

Estimated Revenue & Valuation

  • Surmodics's estimated annual revenue is currently $105.1M per year.(i)
  • Surmodics received $25.0M in venture funding in March 2009.
  • Surmodics's estimated revenue per employee is $340,259
  • Surmodics's current valuation is $657.7M. (January 2022)

Employee Data

  • Surmodics has 309 Employees.(i)
  • Surmodics grew their employee count by -3% last year.

Surmodics's People

NameTitleEmail/Phone
1
SVP & General Manager - Medical Device Business UnitReveal Email/Phone
2
VP Research & DevelopmentReveal Email/Phone
3
VP and Corporate ControllerReveal Email/Phone
4
VP SalesReveal Email/Phone
5
VP, Commercial OperationsReveal Email/Phone
6
VP, Quality, Regulatory & Clinical AffairsReveal Email/Phone
7
VP, Clinical AffairsReveal Email/Phone
8
SVP Legal, General Counsel and SecretaryReveal Email/Phone
9
Director EngineeringReveal Email/Phone
10
VP Finance and Chief Financial OfficerReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$30.6M1224%N/AN/A
#2
$18.6M7435%N/AN/A
#3
$75.6M30120%N/AN/A
#4
$12M484%N/AN/A
#5
$2.8M1110%N/AN/A
#6
$3M120%N/AN/A
#7
$24.6M985%N/AN/A
#8
$11.5M4621%N/AN/A
#9
$7.3M294%N/AN/A
#10
$13.8M55-10%N/AN/A
Add Company

What Is Surmodics?

Surmodics partners with the world's leading and emerging medical device, diagnostic and life sciences companies to develop and commercialize innovative products designed to improve lives by enabling the detection and treatment of disease. Following two recent acquisitions, the company is transforming its medical device business from being a provider of coating technologies, to offering whole-product solutions. Throughout its transformation, Surmodics mission remains: to improve the detection and treatment of disease by using our technology to provide solutions to difficult medical device and diagnostic challenges.

keywords:Biotechnology,Hardware,Hardware Peripherals,Healthcare,Medical Devices,Medical Diagnostics,Pharmaceuticals

N/A

Total Funding

309

Number of Employees

$105.1M

Revenue (est)

-3%

Employee Growth %

$657.7M

Valuation

N/A

Accelerator

Surmodics News

2022-04-19 - Surmodics (SRDX) to Release Earnings on Wednesday

Barclays PLC increased its holdings in shares of Surmodics by 40.1% in the fourth quarter. Barclays PLC now owns 19,159 shares of the company's...

2022-04-19 - Surmodics Q2 2022 Earnings Conference Call On April 27, 2022 At 08:30 AM ET - Benzinga

will host a conference call at 08:30 AM ET on April 27, 2022, to discuss Q2 2022 earnings results. How to Attend Surmodics (SRDX) Conference...

2022-04-19 - Coatings for Medical Application Market Size, Outlook And Forecast ...

SurModics, Sono-Tek, Royal DSM, Hydromer, Biocoat, Specialty Coating Systems, Covalon Technologies, Bayer, PPG Industries, Harland Medical...

2021-08-04 - Surmodics : Reports Third Quarter Fiscal 2021 Results and Updates Fiscal 2021 Revenue and EPS Guidance

Surmodics, Inc. (Nasdaq: SRDX), a leading provider of medical device and in vitro diagnostic technologies to the healthcare industry, today announced results for its fiscal 2021 third quarter ended June 30, 2021 and updated its financial outlook for its fiscal 2021. Summary of Third Quarter and ...

2015-11-20 - SurModics Acquires Creagh Medical for €30M

SurModics, Inc. (Nasdaq: SRDX), an Eden Prairie, Minnesota-based provider of medical device and in vitro diagnostic technologies, acquired Creagh Medical Ltd., a Ballinasloe, Ireland-based developer and manufacturer of percutaneous transluminal angioplasty (PTA) balloon catheters, for €30m (appr ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$57.8M319-8%N/A
#2
$118.5M3276%N/A
#3
$68.1M33917%N/A
#4
$63.3M344-21%$26M
#5
$107.2M35041%N/A

Surmodics Funding

DateAmountRoundLead InvestorsReference
2009-03-05$25.0MUndisclosedWells Fargo Bank NAArticle